Research output per year
Research output per year
Personal profile
Headline
ASSISTANT CLINICAL PROFESSOR
Fingerprint
Dive into the research topics where Bruce Reidenberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes
Hirsch, K. M. & Reidenberg, B. E., Aug 2022, In: Public Health. 209, p. e3-e4Research output: Contribution to journal › Letter › peer-review
Open Access -
Drive through COVID19 vaccination for developmentally disabled persons
Reidenberg, B. E., Hirsch, K., Costello, C. M., Russo, M., Reilly, M. & Murphy, P., 6 Apr 2022, In: Vaccine. 40, 16, p. 2365-2366 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
Johnston, T. H., Versi, E., Howson, P. A., Ravenscroft, P., Fox, S. H., Hill, M. P., Reidenberg, B. E., Corey, R. & Brotchie, J. M., 15 Mar 2018, In: Neuropharmacology. 131, p. 116-127 12 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients
Reidenberg, B. E., Wanner, C., Polsky, B., Castanheira, M., Shelip, A., Stalleicken, D. & Pfaffle, A. E., 1 Apr 2018, In: European Journal of Clinical Microbiology and Infectious Diseases. 37, 4, p. 661-663 3 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Population pharmacokinetics of oxycodone in children 6 months to 7 years old
El-Tahtawy, A., Kokki, H. & Reidenberg, B. E., Apr 2006, In: Journal of Clinical Pharmacology. 46, 4, p. 433-442 10 p.Research output: Contribution to journal › Article › peer-review
37 Scopus citations
Press/Media
-
CorMedix, Inc. (CRMD) CEO Khoso Baluch on Q1 2020 Results - Earnings Call Transcript
Bruce Reidenberg & Bruce Polsky,
12/05/20
1 item of Media coverage
Press/Media
-
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections
Bruce Reidenberg & Bruce Polsky,
6/05/20
1 item of Media coverage
Press/Media
-
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin
Bruce Reidenberg & Bruce Polsky,
6/05/20
1 item of Media coverage
Press/Media
-
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®
Bruce Reidenberg & Bruce Polsky,
6/05/20
15 items of Media coverage
Press/Media
-
CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the ...
5/12/17
1 item of Media coverage
Press/Media